Mutant p53 in bone marrow stromal cells increases VEGF expression and supports leukemia cell growth.

[1]  C. Portwine,et al.  Absence of Germline and Somatic p53 Alterations in Children with Sporadic Brain Tumors , 2001, Journal of Neuro-Oncology.

[2]  Shin-Seok Lee,et al.  Cyclosporine inhibition of vascular endothelial growth factor production in rheumatoid synovial fibroblasts. , 2002, Arthritis and rheumatism.

[3]  S. Rafii,et al.  VEGF(165) promotes survival of leukemic cells by Hsp90-mediated induction of Bcl-2 expression and apoptosis inhibition. , 2002, Blood.

[4]  J. Chipman,et al.  Down-regulation of the DNA-repair endonuclease 8-oxo-guanine DNA glycosylase 1 (hOGG1) by sodium dichromate in cultured human A549 lung carcinoma cells. , 2002, Carcinogenesis.

[5]  M. Tomonaga,et al.  Vascular endothelial growth factor and cellular chemotaxis: a possible autocrine pathway in adult T-cell leukemia cell invasion. , 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.

[6]  E. Freireich,et al.  Angiogenesis and leukemia. , 2001, Leukemia research.

[7]  E. Pásaro,et al.  Effects of styrene-7,8-oxide over p53, p21, bcl-2 and bax expression in human lymphocyte cultures. , 2001, Mutagenesis.

[8]  T. Grogan,et al.  Vascular endothelial cell growth factor is an autocrine promoter of abnormal localized immature myeloid precursors and leukemia progenitor formation in myelodysplastic syndromes. , 2001, Blood.

[9]  T. Tlsty,et al.  Know thy neighbor: stromal cells can contribute oncogenic signals. , 2001, Current opinion in genetics & development.

[10]  O. Bruserud,et al.  Effects of vascular endothelial growth factor on acute myelogenous leukemia blasts. , 2001, Journal of hematotherapy & stem cell research.

[11]  A. Wellmann,et al.  Presence of genetic alterations in microdissected stroma of human colon and breast cancers. , 2001, Journal of molecular medicine.

[12]  L. Gibson,et al.  Stromal cells regulate survival of B-lineage leukemic cells during chemotherapy. , 2000, Blood.

[13]  T. Lebien,et al.  Fates of human B-cell precursors. , 2000, Blood.

[14]  E. Appella,et al.  Signaling to p53: breaking the posttranslational modification code. , 2000, Pathologie-biologie.

[15]  L. Foroni,et al.  Mechanisms of relapse in acute leukaemia: involvement of p53 mutated subclones in disease progression in acute lymphoblastic leukaemia , 1999, British Journal of Cancer.

[16]  T. Grogan,et al.  Expression of vascular endothelial growth factor and its receptors in hematopoietic malignancies. , 1999, Cancer research.

[17]  M. Kobayashi,et al.  Vascular endothelial growth factor inhibits apoptotic death in hematopoietic cells after exposure to chemotherapeutic drugs by inducing MCL1 acting as an antiapoptotic factor. , 1998, Cancer research.

[18]  T. Lebien,et al.  Development of a model for evaluating the interaction between human pre-B acute lymphoblastic leukemic cells and the bone marrow stromal cell microenvironment. , 1998, Blood.

[19]  T. Lebien,et al.  Contact between human bone marrow stromal cells and B lymphocytes enhances very late antigen-4/vascular cell adhesion molecule-1-independent tyrosine phosphorylation of focal adhesion kinase, paxillin, and ERK2 in stromal cells. , 1997, Blood.

[20]  S. Sallan,et al.  Spectrum of tumor angiogenesis in the bone marrow of children with acute lymphoblastic leukemia. , 1997, The American journal of pathology.

[21]  J. Shuster,et al.  High incidence of potential p53 inactivation in poor outcome childhood acute lymphoblastic leukemia at diagnosis. , 1996, Blood.

[22]  F. Behm,et al.  Stroma-supported culture in childhood B-lineage acute lymphoblastic leukemia cells predicts treatment outcome. , 1996, The Journal of clinical investigation.

[23]  A. Howell,et al.  Phenotypic heterogeneity in breast fibroblasts: Functional anomaly in fibroblasts from histologically normal tissue adjacent to carcinoma , 1994, International journal of cancer.

[24]  W. Kolch,et al.  Mutant p53 potentiates protein kinase C induction of vascular endothelial growth factor expression. , 1994, Oncogene.

[25]  K. Dameron,et al.  The p53 tumor suppressor gene inhibits angiogenesis by stimulating the production of thrombospondin. , 1994, Cold Spring Harbor symposia on quantitative biology.

[26]  C. Bartram,et al.  Analysis of p53 mutations in a large series of lymphoid hematologic malignancies of childhood. , 1993, Blood.

[27]  F. Behm,et al.  Bone marrow-derived stromal cells prevent apoptotic cell death in B-lineage acute lymphoblastic leukemia. , 1992, Blood.

[28]  J. D. Funkhouser,et al.  Cancer susceptibility in ataxia-telangiectasia. , 1992, Leukemia.

[29]  M. Minden,et al.  Mutation of the p53 gene in human acute myelogenous leukemia. , 1991, Blood.

[30]  B. Vogelstein,et al.  Mutant p53 DNA clones from human colon carcinomas cooperate with ras in transforming primary rat cells: a comparison of the "hot spot" mutant phenotypes. , 1990, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.